Trade Summary

2 days ago, Mulay James, serving as Dir at Cg Oncology, Inc. (CGON), sold 1,964 shares at $63.50 per share, for a total transaction value of $124,714.00.

This sale represents a 100.00% decrease in Mulay James's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 1 day after the trade was made.

Cg Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.